Read more
1:24 AM Β· 1 August 2025

Apple gains 1.16 % after quarterly results; Apple Intelligence adoption accelerates πŸ“ŒπŸ”Ž

Apple beat expectations in fiscal Q3 2025: revenue rose 10 % y/y to a record USD 94.0 bn, and diluted EPS climbed 12 % to USD 1.57. Growth was driven by strong iPhone, Mac and services sales. Apple shares are up 1.16 % in after-hours trading ahead of the company’s press conference.

Key figures

  • Revenue: USD 94.0 bn (+10 % y/y)
    • iPhone revenue: USD 44.6 bn (+13 %)
    • Services revenue: USD 27.4 bn (+13 %) – new record
  • Earnings per share (EPS): USD 1.57 (+12 %)
  • Gross margin: 46.5 % (up ~20 bp y/y)
  • Operating income: USD 28.2 bn (+11 %)
  • Net income: USD 23.4 bn (+9 %)
  • Cash and equivalents: USD 36.3 bn
  • Quarterly dividend: USD 0.26 per share

In the press release CEO Tim Cook boasted of “double-digit growth in all regions” and stressed that the Apple Intelligence unveiling at WWDC “raised the bar on multiple fronts.” Together with CFO Kevan Parekh he highlighted a record active-device base, all-time-high services revenue and disciplined cost control, all of which lifted EPS. They also confirmed Apple’s commitment to continuing the share-buyback programme and paying a USD 0.26 dividend per share.

As usual, Apple offered no specific numerical guidance, but management cited sustained strong demand for Apple devices, a growing services share and early Apple Intelligence adoption as factors supporting September-quarter results. Additional details will be provided at the press conference. The cash dividend will be paid on 14 August to shareholders of record on 11 August.

Source: xStation 5

14 April 2026, 8:49 PM

AI needs power and that’s where the profits are. Oracle and Bloom set the path.

14 April 2026, 6:13 PM

US OPEN: Wall Street Rallies on Soft PPI Data

14 April 2026, 5:52 PM

Novo Nordisk announces a strategic partnership with OpenAIπŸ§¬πŸ€–

14 April 2026, 4:52 PM

Wells Fargo Q1 2026: Profit Growth Masks Deterioration in Earnings Quality

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.